Vasculopathic Injury and Plasma as Endothelial Rescue in septic shock (SEPSIS) trial

Trial Profile

Vasculopathic Injury and Plasma as Endothelial Rescue in septic shock (SEPSIS) trial

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2017

At a glance

  • Drugs Plasma (Primary)
  • Indications Septic shock
  • Focus Pharmacodynamics
  • Acronyms VIPER-SEPSIS
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Nov 2016 Status changed from recruiting to discontinued.
    • 25 Aug 2016 New source identified and integrated (ClinicalTrials.gov; NCT02875236)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top